Clinical Trials Browser

Phase 1 × Glioblastoma × Cetuximab × Clear all

NCT01238237 2017-02-01

Super-Selective Intraarterial Cerebral Infusion of Cetuximab (Erbitux) for Treatment of Relapsed/Refractory GBM and AA

Phase 1 Completed

Astrocytoma, Brain Neoplasms, Glioblastoma